---
schema_version: "secwatch.filing_event.v1"
accession: "0001809519-24-000006"
form_type: "8-K"
ticker: "GDRX"
cik: "0001809519"
company_name: "GoodRx Holdings, Inc."
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T01:01:08.239549+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# GoodRx pre-announces Q4 revenue above guidance; expects mid-single-digit growth in 2024

## Summary
- Q4 2023 revenue and adjusted revenue expected $195-197M, up ~6-7% YoY and above prior guidance.
- FY 2023 revenue expected $749-751M (-~2% YoY); adjusted revenue $759-761M (-~1% YoY).
- Q4 outperformance driven by organic growth in Prescription Transactions, stronger respiratory season and favorable contracts.
- Early 2024 outlook: Q1 and FY revenue and adjusted revenue to grow mid-single digits YoY; adjusted EBITDA margin in high-twenty% range.
- Full Q4 and 2024 guidance to be provided on February earnings call.

## SEC filing metadata
- accession: 0001809519-24-000006
- form_type: 8-K
- ticker: GDRX
- cik: 0001809519
- company_name: GoodRx Holdings, Inc.
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000006/0001809519-24-000006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000006/gdrx-20240110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001809519-24-000006
- JSON: https://secwatch.observer/filing/0001809519-24-000006.json
- Plain text: https://secwatch.observer/filing/0001809519-24-000006.txt

## Key facts
- Earnings Releases
  GoodRx Holdings, Inc. updated its the fourth quarter and fiscal year ended December 31, 2023 guidance (reaffirmed).
  - Period: the fourth quarter and fiscal year ended December 31, 2023
  - Guidance: reaffirmed
  - Result: preliminary results
  source text: GoodRx Holdings, Inc. (the “Company”) issued a press release announcing the Company’s preliminary estimates of certain financial results for the three months and year ended December 31, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1809519/000180951924000006/0001809519-24-000006-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.